Changzhou Qianhong Biopharma CO.,LTD Operating Cash Flow for the year ending December 31, 2024: USD 70.49 M

Changzhou Qianhong Biopharma CO.,LTD Operating Cash Flow is USD 70.49 M for the year ending December 31, 2024, a -6.16% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Changzhou Qianhong Biopharma CO.,LTD Operating Cash Flow for the year ending December 31, 2023 was USD 75.12 M, a -825.28% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD Operating Cash Flow for the year ending December 31, 2022 was USD -10.36 M, a -163.55% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD Operating Cash Flow for the year ending December 31, 2021 was USD 16.30 M, a -66.47% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD Operating Cash Flow for the year ending December 31, 2020 was USD 48.61 M, a 109.53% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities